enVVeno Medical Corp Quarterly Debt-to-equity in % from Q1 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
enVVeno Medical Corp quarterly Debt-to-equity history and growth rate from Q1 2019 to Q3 2024.
  • enVVeno Medical Corp Debt-to-equity for the quarter ending September 30, 2024 was 6.02 %, a 35.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 6.02 -3.36 -35.8% Sep 30, 2024
Q2 2024 7.01 -0.94 -11.8% Jun 30, 2024
Q1 2024 7.97 +0.83 +11.6% Mar 31, 2024
Q4 2023 8.48 +1.79 +26.7% Dec 31, 2023
Q3 2023 9.38 +3.04 +47.9% Sep 30, 2023
Q2 2023 7.95 +2.87 +56.4% Jun 30, 2023
Q1 2023 7.14 +2.84 +66.1% Mar 31, 2023
Q4 2022 6.69 +2.65 +65.6% Dec 31, 2022
Q3 2022 6.34 +0.92 +17% Sep 30, 2022
Q2 2022 5.08 -4.53 -47.1% Jun 30, 2022
Q1 2022 4.3 -15.8 -78.6% Mar 31, 2022
Q4 2021 4.04 -92.6 -95.8% Dec 31, 2021
Q3 2021 5.42 -171 -96.9% Sep 30, 2021
Q2 2021 9.61 -245 -96.2% Jun 30, 2021
Q1 2021 20.1 -100 -83.3% Mar 31, 2021
Q4 2020 96.6 +7.47 +8.38% Dec 31, 2020
Q3 2020 177 +102 +137% Sep 30, 2020
Q2 2020 254 +188 +285% Jun 30, 2020
Q1 2020 121 +54.4 +82.2% Mar 31, 2020
Q4 2019 89.2 Dec 31, 2019
Q3 2019 74.5 Sep 30, 2019
Q2 2019 66 Jun 30, 2019
Q1 2019 66.1 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.